Applying a Joint Mutual Information (JMI) algorithm, we identified an independent set of 5 peptides (from SMOC1, VGF, APOE ε2/ε3, APOE ε4, and GAPDH) which were able to classify AD-like and Control-like AsymAD cases with 81% accuracy. This evidence concerns the gene GAPDH and Alzheimer disease.